Gerresheimer Rejects Silgan Offer, Shares Rise 1.7%

Gerresheimer turned down Silgan's non‑binding €41 per share takeover approach, ending discussions between the two firms.
Shares initially dropped over 5% on the news but recovered, gaining about 1.7% in European trading by 09:28 GMT.
Gerresheimer is focusing on resolving accounting issues and completing the sale of its U.S. subsidiary Centor before pursuing any deal.
The company’s market value is roughly €742 million, down ~22% YTD after an 80% fall from its 2023 peak.